Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ACP-319 |
Synonyms | |
Therapy Description |
ACP-319 (AMG-319) is an inhibitor of PI3K delta, which may block the proliferation of tumor cells (PMID: 25469863, PMID: 31355927). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ACP-319 | ACP 319|AMG-319|AMG 319 | PIK3CD inhibitor 27 | ACP-319 (AMG-319) is an inhibitor of PI3K delta, which may block the proliferation of tumor cells (PMID: 25469863, PMID: 31355927). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02328014 | Phase Ib/II | ACP-319 Acalabrutinib | ACP-196 in Combination With ACP-319, for Treatment of B-Cell Malignancies | Active, not recruiting | USA | 0 |